HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Hematological indicators as predictors of atrial fibrillation after cardiac surgery

DOI: https://doi.org/10.29296/25877305-2024-01-03

Z. Tatarintseva(1, 2), Candidate of Medical Sciences; Professor E. Kosmacheva(1, 2), MD; A. Shyk(2); A. Batchaeva(2)
1-Research Institute – Prof. S.V. Ochapovsky Territorial Clinical Hospital One, Krasnodar
2-Kuban State Medical University, Ministry of Health of Russia, Krasnodar

Newly diagnosed postoperative atrial fibrillation (NDPAF) is one of the most common complications after cardiovascular surgery, provoking early and late complications, such as cardiovascular, thromboembolic complications, cerebral circulation disorders, prolonged hospital stay and repeated hospitalizations to the intensive care unit and hospital. Objective. To identify biochemical and clinical predictors of NDPAF in patients who underwent open-heart surgery for any indication. Materials and methods. The study included patients operated in the cardiac surgery department No.2 of the Research Institute – Prof. S.V. Ochapovsky Territorial Clinical Hospital One (Krasnodar) in the period from January 1, 2020 to January 1, 2021. During the analyzed period of time, open heart surgery was performed in 1503 patients, of whom 158 (10.5%) had NDPAF. Results. Hematological/biochemical parameters include low levels of hemoglobin (55 U/L), C-reactive protein (>5 mg/L) were associated with an increased frequency of NDPAF in single-factor analysis (p

postoperative atrial fibrillation
cardiac surgery
hematological predictors
open heart surgery
atrial fibrillation
coronary artery bypass grafting.

  1. Luo W., Huaibin W., Wenjun Z. et al. Predictors of postoperative atrial fibrillation after isolated on-pump coronary artery bypass grafting in patients ≥60 years old. Heart Surg Forum. 2017; 20 (1): E038–E042. DOI: 10.1532/hsf.1583
  2. Mirhosseini S.J., Forouzannia S.K., Sayegh A.H. et al. Effect of prophylactic low dose of methylprednisolone on postoperative new atrial fibrillation and early complications in patients with severe LV dysfunction undergoing elective off-pump coronary artery bypass surgery. Acta Med Iran. 2011; 49 (5): 288–92.
  3. Sabashnikov A., Weymann A., Haldar S. et al. Position of totally thoracoscopic surgical ablation in the treatment of atrial fibrillation: an alternative method of conduction testing. Med Sci Monit Basic Res. 2015; 21: 76–80. DOI: 10.12659/MSMBR.894239
  4. Li T., Sun Z.L., Xie Q.Y. Meta-analysis identifies serum C-reactive protein as an indicator of atrial fibrillation risk after coronary artery bypass graft. Am J Ther. 2016; 23 (6): e1586–e1596. DOI: 10.1097/MJT.0000000000000255
  5. Bessissow A., Khan J., Devereaux P.J. et al. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost. 2015; 13: 304–12. DOI: 10.1111/jth.12974
  6. Nair S.G. Atrial fibrillation after cardiac surgery. Ann Card Anaesth. 2010; 13 (3): 196–205. DOI: 10.4103/0971-9784.69047
  7. Danelich I.M., Lose J.M., Wright S.S. et al. Practical management of postoperative atrial fibrillation after noncardiac surgery. J Am Coll Surg. 2014; 219 (4): 831–41. DOI: 10.1016/j.jamcollsurg.2014.02.038
  8. Dobrev D., Aguilar M., Heijman J. et al. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol. 2019; 16 (7): 417–36. DOI: 10.1038/s41569-019-0166-5
  9. Turagam M.K., Mirza M., Werner P.H. et al. Circulating biomarkers predictive of postoperative atrial fibrillation. Cardiol Rev. 2016; 24 (2): 76–87. DOI: 10.1097/CRD.0000000000000059
  10. Guan B., Li X., Xue W. et al. Blood lipid profiles and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Clin Lipidol. 2020; 14 (1): 133–42. DOI: 10.1016/j.jacl.2019.12.002
  11. Li X.Y., Hou H.T., Chen H.X. et al. Preoperative plasma biomarkers associated with atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2021; 162 (3): 851–863.e3. DOI: 10.1016/j.jtcvs.2020.01.079
  12. Gorczyca I., Michta K., Pietrzyk E. et al. Predictors of post-operative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting. Kardiol Pol. 2018; 76 (1): 195–201. DOI: 10.5603/KP.a2017.0203
  13. Cerit L., Kemal H., Gulsen K. et al. Relationship between Vitamin D and the development of atrial fibrillation after on-pump coronary artery bypass graft surgery. Cardiovasc J Afr. 2017; 2: 104–7. DOI: 10.5830/CVJA-2016-064
  14. Chua S.K., Shyu K.G., Lu M.J. et al. Association between renal function, diastolic dysfunction, and postoperative atrial fibrillation following cardiac surgery. Circ J. 2013; 77 (9): 2303–10. DOI: 10.1253/circj.CJ-13-0273
  15. January C.T., Wann L.S., Calkins H. et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019; 74 (1): 104–32 [Erratum in: J Am Coll Cardiol. 2019; 74 (4): 599]. DOI: 10.1016/j.jacc.2019.01.011
  16. Kinoshita T., Asai T., Takashima N. et al. Preoperative C-reactive protein and atrial fibrillation after off-pump coronary bypass surgery. Eur J Cardiothorac Surg. 2011; 40 (6): 1298–303. DOI: 10.1016/j.ejcts.2011.03.027
  17. Şaşkin H., Düzyol Ç., Aksoy R. et al. Do preoperative C-reactive protein and mean platelet volume levels predict development of postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting? Postepy Kardiol Interwencyjnej. 2016; 12 (2): 156–63. DOI: 10.5114/aic.2016.59366
  18. Weymann A., Ali-Hasan-Al-Saegh S., Sabashnikov A. et al. Prediction of new-onset and recurrent atrial fibrillation by complete blood count tests: a comprehensive systematic review with meta-analysis. Med Sci Monit Basic Res. 2017; 12 (23): 179–222. DOI: 10.12659/msmbr.903320
  19. Abbaszadeh S., Shafiee A., Bina P. et al. Preoperative hemoglobin A1c and the occurrence of atrial fibrillation following on-pump coronary artery bypass surgery in type-2 diabetic patients. Crit Pathw Cardiol. 2017; 16 (1): 37–41. DOI: 10.1097/HPC.0000000000000103
  20. Zhao H., Liu M., Chen Z. et al. Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes. PLoS One. 2020; 15 (2): e0227262. DOI: 10.1371/journal.pone.0227262
  21. Demir M., Demir C., Uyan U. et al. The relationship between serum bilirubin concentration and atrial fibrillation. Cardiol Res. 2013; 4 (6): 186–91. DOI: 10.4021/cr299w
  22. Sun D., Li W., Zheng W. et al. Direct bilirubin level is an independent risk factor for atrial fibrillation in thyrotoxic patients receiving radioactive iodine therapy. Nucl Med Commun. 2019; 40 (12): 1289–94. DOI: 10.1097/MNM.0000000000001107
  23. Ali-Hassan-Sayegh S., Mirhosseini S.J., Haddad F. et al. Protective effects of corticosteroids in coronary artery bypass graft surgery alone or combined with valvular surgery: an updated and comprehensive meta-analysis and systematic review. Interact Cardiovasc Thorac Surg. 2015; 20 (6): 825–36. DOI: 10.1093/icvts/ivv033
  24. Дедов Д., Эльгардт И., Масюков С. и др. Электрическое ремоделирование миокарда и прогноз у больных с фибрилляцией предсердий. Врач. 2015; 11: 77–9 [Dedov D., Elgardt I., Masyukov S. et al. Myocardial electrical remodelling and prognosis in patients with atrial fibrillation. Vrach. 2015; 11: 77–9 (In Russ.)].